Innoviva, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their products on animals to assess it’s safety profile.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“Studies in animals have shown reproductive toxicity at exposures which are not clinically relevant.” (Page 28) Read the following document
Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist (LABA), vilanterol (VI), and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA. [Source: MarketWatch]
Company Website: http://www.inva.com